about
Use of rifaximin in gastrointestinal and liver diseasesRelationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome.Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic DichotomyComparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.Is the intestinal gas associated with the development of right colonic diverticula?Antibiotics for irritable bowel syndrome: rationale and current evidence.Mechanisms and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management of digestive disorders.Gas and the microbiome.Evidence-based clinical practice guidelines for irritable bowel syndrome.Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.Antibiotics for the treatment of irritable bowel syndromeReview article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage.Antibiotics as deep modulators of gut microbiota: between good and evil.Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders.Lactulose Hydrogen Breath Test Result Is Associated with Age and GenderMeta-analysis: antibiotic therapy for small intestinal bacterial overgrowth.Irritable bowel syndrome: emerging paradigm in pathophysiology.Gastrointestinal pH profile in subjects with irritable bowel syndrome.Methane on breath testing is associated with constipation: a systematic review and meta-analysis.Existing and emerging therapies for irritable bowel syndrome.Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects.The role of rifaximin therapy in patients with irritable bowel syndrome without constipation.The intestinal microbiota and chronic disorders of the gut.The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis.Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment.Microbiome, antibiotics and irritable bowel syndrome.Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.Gut fermentation seems to promote decompression sickness in humans.A definitive blood test for post-infectious irritable bowel syndrome?Irritable bowel syndrome in women.Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.Antibiotic treatment of constipation-predominant irritable bowel syndrome.Erosive esophagitis may be related to small intestinal bacterial overgrowth.The role of small intestinal bacterial overgrowth in postgastrectomy patients.Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV.Methanogens in Human Health and Disease
P2860
Q26740201-9EEAEECC-75CE-432B-AC30-B95C11EC8538Q33449179-8FC48EE0-41F4-4531-93BF-6EA6066BFF1BQ33456102-94598CDB-19AF-47F5-9641-015601443397Q33469991-9BCCB364-D222-44FB-BDD3-65DF75940A09Q34454007-E7AD31B9-188B-4731-B4CB-D3E999882EFBQ34588737-364AF18E-CA36-4D37-84CA-246448F5F08EQ34642080-45CD87DF-2E9E-4ADA-8B2A-7C3C71899077Q34726491-C1008D4E-B6B1-40D8-84F2-53A159B9A5FAQ35024458-3857405F-6023-41B5-B2B0-B6C93C487142Q35513973-FFE427CD-2308-43F1-B6C9-ED13DC9E1793Q35599906-AEF41E60-27A3-4F93-BD27-88F793495F75Q35603014-10875C96-8591-47A9-80C7-4AE2C201D90FQ35691133-2BCF9173-B369-4A35-A906-E9A604562210Q35855740-8CAC0B92-1473-4C0A-A30B-4306C20471BDQ36073385-BA287F06-5D58-4516-8714-7D7BC4CB517FQ36105508-843DFD81-A922-4588-BFD9-37F2204287D4Q36426034-C534EE3E-D7D6-48F0-BB84-377477707268Q36747480-7EC24CC9-0F6E-456E-957C-B84B7A091D9FQ37284278-8F280D3F-D585-4C39-9546-99AFEF38A470Q37629670-3886EFDE-E408-40B1-8809-88A3780945C0Q37647417-A27D2B8D-AA0F-48E2-96D1-B921B181664CQ37834415-CCAE2E47-49BA-4E9D-BFF6-34FAA7D6DEF6Q37857849-35142239-2DBB-4008-99BD-5A892EE4F604Q37874146-06041903-EACD-4AB2-AD6F-DA3D461FB5D9Q37903847-99838FE2-8B65-4D31-B0E7-B18ADEFAC983Q37918323-FCB9550C-2023-46F9-866C-DF26136A015FQ37951770-EBFE9C1F-467B-45E4-93EA-42CD08E06141Q38129946-92FA98AA-3623-4677-99EF-6F49FAC050B2Q38811947-04F8BD36-C42E-4C50-B059-9128121B1E0BQ39022623-1C486F4A-19B9-4253-80D0-02401BDDED91Q42289564-30161FFA-4555-486A-A575-8CA6CA477F10Q46467997-59C00563-B3EC-461F-AF75-AB8FC813F6DCQ46484371-832B15D0-0437-4E2F-90D2-36C48BB3DCA7Q48325807-284E934D-B1D4-4B1D-B8B7-A8D402FA1E41Q49985626-9671E326-F034-4794-8876-A5EAE5D7EC95Q51726426-E9F63332-EF12-4D4C-BF7B-6A63B26F334EQ53384067-8CBB9AAC-BF39-4091-AA71-3F0A74BC44ADQ53438153-FB8EBB1B-8886-4479-B9FA-9C124410BEDCQ54245944-D178D4E5-BCD0-4AA7-A08D-7AAE3966046AQ56048193-34D78E7A-D8CF-4C95-AB52-F22AEF960FF6
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Abnormal breath testing in IBS: a meta-analysis.
@ast
Abnormal breath testing in IBS: a meta-analysis.
@en
Abnormal breath testing in IBS: a meta-analysis.
@nl
type
label
Abnormal breath testing in IBS: a meta-analysis.
@ast
Abnormal breath testing in IBS: a meta-analysis.
@en
Abnormal breath testing in IBS: a meta-analysis.
@nl
prefLabel
Abnormal breath testing in IBS: a meta-analysis.
@ast
Abnormal breath testing in IBS: a meta-analysis.
@en
Abnormal breath testing in IBS: a meta-analysis.
@nl
P2093
P1476
Abnormal breath testing in IBS: a meta-analysis.
@en
P2093
Eric D Shah
Kelly Chong
Robert J Basseri
P2888
P304
P356
10.1007/S10620-010-1276-4
P577
2010-05-14T00:00:00Z
P6179
1052749079